← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Provid Pharmaceuticals, Inc
North Brunswick, NJ
$1,422,848
Total funding
8
Grants
Funding over time
peak $239.3K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,422,848 · 8
By mechanism
R43$1,085,295 · 6
R41$187,995 · 1
N43$149,558 · 1
Investigators at Provid Pharmaceuticals, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Antibacterial RNA Polymerase Inhibitors$268,433
R43 · FY2002 · AI
TRAIL Upregulation by TIC10 Analogs$224,960
R43 · FY2014 · CA
QBP1 Mimetics as Therapeutics for Huntington's Disease$187,995
R41 · FY2004 · NS
F11R antagonists for atherosclerosis$175,200
R43 · FY2010 · HL
402 - RFP: N43-CM-87007-68 Topic 251: Development of Anticancer Agents Reques$149,558
N43 · FY2008 · CA
Inhibitors of Protein Kinase A Localization in the Heart$132,414
R43 · FY2005 · HL
MHC Class II inhibitors for Multiple Sclerosis$109,997
R43 · FY2004 · NS
Design and Assay of DQ2 Inhibitors for Celiac Disease$106,881
R43 · FY2005 · DK
MHC Class II inhibitors for Multiple Sclerosis$67,410
R43 · FY2007 · NS